Correction to “A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung”
Author(s) -
Gloria S. Forkuo,
Amanda N. Nieman,
Revathi Kodali,
Nicolas M. Zahn,
Guanguan Li,
M. S. Rashid Roni,
Michael Rajesh Stephen,
Ted W. Harris,
Rajwana Jahan,
Margaret L. Guthrie,
Olivia B. Yu,
Janet L. Fisher,
Gene T. Yocum,
Charles W. Emala,
Douglas A. Steeber,
Douglas C. Stafford,
James M. Cook,
Leggy A. Arnold
Publication year - 2019
Publication title -
molecular pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 127
eISSN - 1543-8392
pISSN - 1543-8384
DOI - 10.1021/acs.molpharmaceut.9b01053
Subject(s) - asthma , inflammation , receptor , medicine , drug , pharmacology , constriction , smooth muscle , lung , drug candidate
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom